These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21054463)
1. ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations. Kim KA; Joo HJ; Park JY J Clin Pharm Ther; 2010 Dec; 35(6):705-12. PubMed ID: 21054463 [TBL] [Abstract][Full Text] [Related]
2. Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote. Wan Z; Wang G; Li T; Xu B; Pei Q; Peng Y; Sun H; Cheng L; Zeng Y; Yang G; Zhu YS J Pharmacol Exp Ther; 2015 Sep; 354(3):310-5. PubMed ID: 26081159 [TBL] [Abstract][Full Text] [Related]
3. Associations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese population. Wang C; Xie L; Li H; Li Y; Mu D; Zhou R; Liu R; Zhou K; Hua Y DNA Cell Biol; 2014 Oct; 33(10):689-98. PubMed ID: 24979295 [TBL] [Abstract][Full Text] [Related]
4. ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition. de Jong FA; Marsh S; Mathijssen RH; King C; Verweij J; Sparreboom A; McLeod HL Clin Cancer Res; 2004 Sep; 10(17):5889-94. PubMed ID: 15355921 [TBL] [Abstract][Full Text] [Related]
5. Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles. Kim KA; Song WK; Kim KR; Park JY J Clin Pharm Ther; 2010 Dec; 35(6):697-703. PubMed ID: 21054462 [TBL] [Abstract][Full Text] [Related]
6. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Zhou Q; Ruan ZR; Yuan H; Xu DH; Zeng S Pharmazie; 2013 Feb; 68(2):129-34. PubMed ID: 23469685 [TBL] [Abstract][Full Text] [Related]
7. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions. Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748 [TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity. Tamura M; Kondo M; Horio M; Ando M; Saito H; Yamamoto M; Horio Y; Hasegawa Y Nagoya J Med Sci; 2012 Feb; 74(1-2):133-40. PubMed ID: 22515119 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms. Zhou Q; Ruan ZR; Jiang B; Yuan H; Zeng S Pharmazie; 2013 Feb; 68(2):124-8. PubMed ID: 23469684 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Słomka M; Sobalska-Kwapis M; Korycka-Machała M; Dziadek J; Bartosz G; Strapagiel D Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33003314 [TBL] [Abstract][Full Text] [Related]
11. Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non-small-cell lung cancer. Akasaka K; Kaburagi T; Yasuda S; Ohmori K; Abe K; Sagara H; Ueda Y; Nagao K; Imura J; Imai Y Cancer Chemother Pharmacol; 2010 Sep; 66(4):691-8. PubMed ID: 20035425 [TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of ABCG2 and SLC2A9 gene polymorphisms in gouty arthritis in a Korean population. Kim YS; Kim Y; Park G; Kim SK; Choe JY; Park BL; Kim HS Korean J Intern Med; 2015 Nov; 30(6):913-20. PubMed ID: 26552468 [TBL] [Abstract][Full Text] [Related]
14. Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype. Miura Y; Imamura CK; Fukunaga K; Katsuyama Y; Suyama K; Okaneya T; Mushiroda T; Ando Y; Takano T; Tanigawara Y BMC Cancer; 2014 Dec; 14():964. PubMed ID: 25515134 [TBL] [Abstract][Full Text] [Related]
15. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531 [TBL] [Abstract][Full Text] [Related]
16. Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers. Li N; Song Y; Du P; Shen Y; Yang J; Gui L; Wang S; Wang J; Sun Y; Han X; Shi Y Biomed Pharmacother; 2013 Oct; 67(8):801-6. PubMed ID: 24074809 [TBL] [Abstract][Full Text] [Related]
17. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans. Kim KA; Cha YJ; Lee HM; Joo HJ; Park JY Clin Chim Acta; 2015 Jan; 438():7-11. PubMed ID: 25124867 [TBL] [Abstract][Full Text] [Related]
18. Interindividual Regulation of the Breast Cancer Resistance Protein/ Bircsak KM; Moscovitz JE; Wen X; Archer F; Yuen PYS; Mohammed M; Memon N; Weinberger BI; Saba LM; Vetrano AM; Aleksunes LM Drug Metab Dispos; 2018 May; 46(5):619-627. PubMed ID: 29386232 [TBL] [Abstract][Full Text] [Related]
19. Multiplex pyrosequencing method to determine CYP2C9*3, VKORC1*2, and CYP4F2*3 polymorphisms simultaneously: its application to a Korean population and comparisons with other ethnic groups. Kim KA; Song WG; Lee HM; Joo HJ; Park JY Mol Biol Rep; 2014 Nov; 41(11):7305-12. PubMed ID: 25069408 [TBL] [Abstract][Full Text] [Related]
20. Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients. Lal S; Wong ZW; Sandanaraj E; Xiang X; Ang PC; Lee EJ; Chowbay B Cancer Sci; 2008 Apr; 99(4):816-23. PubMed ID: 18377430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]